🇺🇸 Ferrous Sulfate tablets in United States

27 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pneumonia — 5 reports (18.52%)
  2. Deep Vein Thrombosis — 4 reports (14.81%)
  3. Anaemia — 3 reports (11.11%)
  4. Haemoglobin Decreased — 3 reports (11.11%)
  5. Asthenia — 2 reports (7.41%)
  6. Blood Creatinine Increased — 2 reports (7.41%)
  7. Cardiac Failure Congestive — 2 reports (7.41%)
  8. Coma — 2 reports (7.41%)
  9. Condition Aggravated — 2 reports (7.41%)
  10. Dehydration — 2 reports (7.41%)

Source database →

Ferrous Sulfate tablets in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ferrous Sulfate tablets approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ferrous Sulfate tablets in United States?

American Regent, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.